(Total Views: 111)
Posted On: 04/11/2019 2:50:40 PM
Post# of 21237

$SAN News Article - Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC) https://marketwirenews.com/news-releases/heal...86880.html


My Twitter: WhyteStocks